文献速递角膜与眼表疾病

地夸磷索钠通过激活Erk1/2和RSK抑制角膜上皮细胞凋亡与炎症

Diquafosol Sodium Inhibits Apoptosis and Inflammation of Corneal Epithelial Cells Via Activation of Erk1/2 and RSK: In Vitro and In Vivo Dry Eye Model.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

该研究在体外干燥应激模型和东莨菪碱诱导的干眼大鼠模型中评估地夸磷索对 corneal epithelium 的作用。地夸磷索降低了细胞内ROS水平、凋亡和炎症,并上调 phospho-Erk1/2、phospho-p90RSK、phospho-Akt 和 IκB-α,同时降低 NF-κB-p65、IL-1β 和 TNF-α。体内实验显示地夸磷索滴眼可减轻凋亡并上调 phospho-p90RSK 和 phospho-ERK1/2、下调 IL-1β。

要点

  • 地夸磷索减少干眼模型角膜上皮细胞的ROS生成和凋亡。
  • 地夸磷索激活Erk1/2和p90RSK通路并抑制NF-κB相关炎症因子。
  • 体内滴眼可减轻干眼大鼠角膜凋亡和IL-1β水平。

核心结论

  • 地夸磷索治疗可降低干眼模型中增高的细胞内ROS、凋亡和炎症。

研究设计与样本

  • 体外采用Transwell培养人角膜上皮细胞构建干燥应激干眼模型,地夸磷索培养基按1:100稀释孵育。
  • 体内采用东莨菪碱氢溴酸盐诱导Wistar大鼠干眼模型,分为对照组、干眼组和干眼地夸磷索组。
  • 干眼地夸磷索组局部滴用DIQUAS每日四次,持续28天。

主要发现

  • 地夸磷索培养基中高荧光二氯荧光素分布和annexin V及PI阳性细胞比例降低。
  • 地夸磷索增加phospho-Erk1/2、phospho-90RSK、phospho-Akt和IκB-α水平,显著降低NF-κB-p65、IL-1β和TNF-α水平。
  • 体内干眼组凋亡增强,DIQUAS显著减轻该反应并上调phosphorylated p90RSK和phosphorylated ERK1/2、下调IL-1β。

临床怎么用

  • 地夸磷索可能通过激活Erk1/2-RSK通路和抑制NF-κB炎症信号保护干眼角膜上皮。
  • 该研究为地夸磷索在干眼角膜上皮损伤中的抗凋亡和抗炎作用提供了体外和体内证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effect of diquafosol on corneal epithelium in a dry eye model using Transwell culture and a scopolamine-induced dry eye rat model. METHODS: Desiccation stress induced in an in vitro dry eye model using human corneal epithelial cells was used, and the cells were incubated with or without diquafosol media diluted at 1:100. Reactive oxygen species (ROS) generation was measured using 2',7'-dichlorofluorescein diacetate (DCFH-DA). Apoptosis was analyzed, and levels of phosphorylated Erk1/2, phosphorylated p90RSK, phosphorylated Akt, IκB-α, and NF-κB-p65 were determined. Levels of IL-1β, TNF-α, IL-6, IL-8, and GM-CSF were quantified. To investigate the in vivo effects of diquafosol, we induced dry eye in Wistar rats using scopolamine hydrobromide. The rats were divided into three groups: control, dry eye, and dry eye diquafosol; topical DIQUAS was applied four times daily for 28 days. We used immunohistochemistry to detect the levels of phosphorylated Erk1/2, phosphorylated p90RSK, and IL-1β, and used the TUNEL assay in corneal tissue. RESULTS: The distribution of highly fluorescent dichlorofluorescein and the proportion of annexin V- and PI-positive cells decreased in the diquafosol medium. Diquafosol increased the levels of phospho-Erk1/2, phospho-90RSK, phospho-Akt, and IκB-α, whereas it significantly decreased the levels of NF-κB-p65, IL-1β, and TNF-α. In vivo, apoptosis was enhanced in dry eye group. This response was markedly reduced and the level of phosphorylated p90RSK and phosphorylated ERK1/2 were upregulated and IL-1β was downregulated by DIQUAS. CONCLUSIONS: Diquafosol treatment reduced intracellular ROS levels, apoptosis, and inflammation, all of which were increased in the dry eye model through desiccation.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Park JH, Moon SH, Kang DH, et al. Diquafosol Sodium Inhibits Apoptosis and Inflammation of Corneal Epithelial Cells Via Activation of Erk1/2 and RSK: In Vitro and In Vivo Dry Eye Model. Invest Ophthalmol Vis Sci. 2018. PMID: 30372737. doi:10.1167/iovs.17-22925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。